Waldencast PLC (WALD) News

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

WHITE PLAINS, N.Y., June 27, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global...

Waldencast Announces Participation in Upcoming Investor Conferences

WHITE PLAINS, N.Y., May 30, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the...

Waldencast Reports Q1 2024 Financial Results

$68.3 million of Net Revenue+21.0% Comparable Net Revenue: +20.6% Obagi Skincare and +21.5% Milk MakeupAdjusted...

Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast

NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global...

Waldencast Announces Participation in CreatorIQ Connect Europe

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a...

Waldencast Reports Fiscal Year 2023 Financial Results

2023 Net Revenue of $218.1 millionGroup Combined Comparable Revenue of $212.5 million, a 15.3% increase vs...

Waldencast Regains Compliance with Nasdaq Filing Requirements

WHITE PLAINS, N.Y., March 25, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a...

Waldencast Reports First Half 2023 Results

—  H1’23 Total Net Revenue of $109.3 million—  H1’23 Combined Adjusted EBITDA of $13.9 million up from $7.6...

Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in...

Waldencast Receives Positive Nasdaq Listing Determination

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors

NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a...

Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.

LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in...